Stay updated on Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has removed a detailed citation for a clinical trial regarding Cabozantinib versus Sunitinib, which included an erratum and additional references.
    Difference
    0.6%
    Check dated 2025-05-07T19:03:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.1%
    Check dated 2025-04-30T13:45:31.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study criteria and descriptions related to a clinical trial for Collecting Duct Carcinoma, while adding a new revision number and a mention of a single group assignment model.
    Difference
    25%
    Check dated 2025-04-16T01:39:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:11:13.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:24:07.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:58:50.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page.